| Dr David Witham, MD | |
|
1001 Noble St, Fairbanks, AK 99701-4922 | |
| (907) 459-3500 | |
| (907) 459-3532 |
| Full Name | Dr David Witham |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 41 Years |
| Location | 1001 Noble St, Fairbanks, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457328197 | NPI | - | NPPES |
| MD4545 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 4607 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fairbanks Memorial Hospital | Fairbanks, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tanana Valley Clinic Llc | 5698056901 | 105 |
News Archive
Laboratory Corporation of America Holdings announced today the immediate availability of an enhanced version of its HCV GenoSure NS3/4, a drug resistance test that screens for the Q80K polymorphism. Q80K is a naturally occurring polymorphism that develops in certain strains of HCV, making the virus less susceptible to Janssen Therapeutics' OLYSIO (simeprevir), which was recently approved by the U.S. Food and Drug Administration for the treatment of certain adult patients diagnosed with genotype 1chronic hepatitis C.
The protein tumor necrosis factor-alpha (TNF-alpha) is a powerful weapon in the arsenal to control cancer. Unfortunately, as is the case with many potent cancer therapies, the use of TNF-alpha as an anti-cancer therapy has been severely limited.
The latest food scare over beef possibly contaminated with E. coli, has left many consumers in the U.S. wondering just how safe the food they buy really is.
Early premature birth at less than 34 weeks was associated with symptoms of attention-deficit/hyperactivity disorder in preschool-age children and inattention symptoms in school-age children.
› Verified 9 days ago
| Entity Name | David M. Witham Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194918367 PECOS PAC ID: 6305938283 Enrollment ID: O20070823000394 |
News Archive
Laboratory Corporation of America Holdings announced today the immediate availability of an enhanced version of its HCV GenoSure NS3/4, a drug resistance test that screens for the Q80K polymorphism. Q80K is a naturally occurring polymorphism that develops in certain strains of HCV, making the virus less susceptible to Janssen Therapeutics' OLYSIO (simeprevir), which was recently approved by the U.S. Food and Drug Administration for the treatment of certain adult patients diagnosed with genotype 1chronic hepatitis C.
The protein tumor necrosis factor-alpha (TNF-alpha) is a powerful weapon in the arsenal to control cancer. Unfortunately, as is the case with many potent cancer therapies, the use of TNF-alpha as an anti-cancer therapy has been severely limited.
The latest food scare over beef possibly contaminated with E. coli, has left many consumers in the U.S. wondering just how safe the food they buy really is.
Early premature birth at less than 34 weeks was associated with symptoms of attention-deficit/hyperactivity disorder in preschool-age children and inattention symptoms in school-age children.
› Verified 9 days ago
| Entity Name | Tanana Valley Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922559558 PECOS PAC ID: 5698056901 Enrollment ID: O20161228001991 |
News Archive
Laboratory Corporation of America Holdings announced today the immediate availability of an enhanced version of its HCV GenoSure NS3/4, a drug resistance test that screens for the Q80K polymorphism. Q80K is a naturally occurring polymorphism that develops in certain strains of HCV, making the virus less susceptible to Janssen Therapeutics' OLYSIO (simeprevir), which was recently approved by the U.S. Food and Drug Administration for the treatment of certain adult patients diagnosed with genotype 1chronic hepatitis C.
The protein tumor necrosis factor-alpha (TNF-alpha) is a powerful weapon in the arsenal to control cancer. Unfortunately, as is the case with many potent cancer therapies, the use of TNF-alpha as an anti-cancer therapy has been severely limited.
The latest food scare over beef possibly contaminated with E. coli, has left many consumers in the U.S. wondering just how safe the food they buy really is.
Early premature birth at less than 34 weeks was associated with symptoms of attention-deficit/hyperactivity disorder in preschool-age children and inattention symptoms in school-age children.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Witham, MD 1001 Noble St, Fairbanks, AK 99701-4922 Ph: (907) 459-3500 | Dr David Witham, MD 1001 Noble St, Fairbanks, AK 99701-4922 Ph: (907) 459-3500 |
News Archive
Laboratory Corporation of America Holdings announced today the immediate availability of an enhanced version of its HCV GenoSure NS3/4, a drug resistance test that screens for the Q80K polymorphism. Q80K is a naturally occurring polymorphism that develops in certain strains of HCV, making the virus less susceptible to Janssen Therapeutics' OLYSIO (simeprevir), which was recently approved by the U.S. Food and Drug Administration for the treatment of certain adult patients diagnosed with genotype 1chronic hepatitis C.
The protein tumor necrosis factor-alpha (TNF-alpha) is a powerful weapon in the arsenal to control cancer. Unfortunately, as is the case with many potent cancer therapies, the use of TNF-alpha as an anti-cancer therapy has been severely limited.
The latest food scare over beef possibly contaminated with E. coli, has left many consumers in the U.S. wondering just how safe the food they buy really is.
Early premature birth at less than 34 weeks was associated with symptoms of attention-deficit/hyperactivity disorder in preschool-age children and inattention symptoms in school-age children.
› Verified 9 days ago
Jimmy M. Tamai, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1275 Sadler Way, Ste 101, Fairbanks, AK 99701 Phone: 907-374-4463 Fax: 907-374-7072 | |
Daniel R Johnson, D.O. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3745 Geist Road, Fairbanks, AK 99709 Phone: 907-456-3338 | |
Dr. Robert Denison Dingeman, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 751 Old Richardson Hwy, Suite 101, Fairbanks, AK 99701 Phone: 907-452-2663 Fax: 907-456-3033 | |
Neal Everson, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2310 Peger Rd Ste 105, Fairbanks, AK 99709 Phone: 907-479-2663 Fax: 907-479-2691 | |
Dr. Mark Alan Wade, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2310 Peger Rd, Ste 105, Fairbanks, AK 99709 Phone: 907-479-2663 Fax: 907-479-2691 | |
Dr. Gary Ian Molk, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1919 Lathrop St Ste 105, Fairbanks, AK 99701 Phone: 907-459-3545 Fax: 907-328-0474 |